RETROVIR, a drug licensed in Britain for treating people with AIDS or
other symptoms of infection with HIV, may soon be available for treating
people with HIV who have shown no sign of illness. The Wellcome Foundation,
the British pharmaceuticals company, announced this week that it had won
provisional clearance from the Committee for Proprietary Medicinal Products
of the European Commission to seek wider use for Retrovir. Individual member
states of the EC are now considering the committee’s recommendations.
More from New ¾«¶«´«Ã½
Explore the latest news, articles and features
Environment
'The book is in the future, but everything is seeded from our present'
Culture
Space
Millions of planets might form around supermassive black holes
News
Comment
Unsettling dance piece explores how AI is warping human relationships
Culture
Comment
Is there a word for the Wiki page for the Ship of Theseus paradox?
Regulars
Popular articles
Trending New ¾«¶«´«Ã½ articles
1
Does gravity create reality? A shocking path to a theory of everything
2
Embryos made without sperm or eggs reveal why many pregnancies fail
3
First quantum grandfather clock could probe where gravity comes from
4
Photos reveal unexpected details from the world's first atomic test
5
Millions of planets might form around supermassive black holes
6
Experimental mRNA vaccine may protect against multiple Ebola viruses
7
'The book is in the future, but everything is seeded from our present'
8
The day quantum computers break the internet
9
Earth from Above author returns with astonishing freshwater images
10
Wealthy people with environmental ideals are the biggest emitters
